News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Seeking Alpha Earnings
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Natera stock has delivered a very large 3 year gain, yet its valuation checks send mixed signals, with a Discounted Cash Flow (DCF) …
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Natera (NTRA) has drawn fresh attention after announcing a new collaboration that puts its Latitude molecular residual disease test into a Phase 1 clinical trial …
This article provides a price-driven analysis of Central Plains Bancshares Inc. Com (NASDAQ: CPBI), indicating a near-term neutral sentiment amidst mid and long-term strength. It highlights compelling upside potential with no resistance levels above the current price and presents three institutional trading strategies tailored …
5 Insightful Analyst Questions From Natera's Q2 Earnings Call Natera's second quarter results were positively received by the market, driven by robust sales volume growth and ongoing momentum in both established and emerging product lines. Management attributed the quarter's strength to record-breaking test volumes—particularly …
Jonathan Sheena, a director at Natera, Inc. (NASDAQ:NTRA), sold 6,000 shares of common stock totaling approximately $1.95 million on August 10, 2026. This sale was conducted under a Rule 10b5-1 trading plan. Despite the stock surging 90% over the past year, InvestingPro analysis indicates …
Concentra Group Holdings Parent Inc. stock has reached an all-time high of $35.16, contributing to a market capitalization of $4.48 billion and marking a 79% year-to-date return. Despite its overvalued status according to InvestingPro, the company demonstrates strong financial health with a Piotroski Score …
The article analyzes Central Garden & Pet Company Class A Common Stock Nonvoting (CENTA) using AI models, highlighting a mid-channel oscillation pattern and divergent sentiment across different time horizons. It provides three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and …
Central Garden & Pet (CENT) is projected to have a 45% upside to a $65 target price due to its discounted valuation and strategic expansion, including the acquisition of TRIXIE which makes it a global leader. The company has improved its margins to 13% …
American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute for Medical Research have reported a beneficial ownership of 2,598,623 shares, or 5.1%, of Central Garden & Pet Company's Class A Common Stock as of June 30, 2026. The entities possess …
The diagnostics stock’s latest weekly move extended a sharp three-month advance, with turnover running above its recent average.
Concentra Group Holdings Parent (NYSE:CON) has reached a new 52-week high of $35.33, driven by positive analyst sentiment and strong financial performance. The company surpassed quarterly earnings expectations with an EPS of $0.52 and revenue of $606.03 million, marking a 10% year-over-year increase. Despite …
Armistice Capital, LLC and Steven Boyd have reported a beneficial ownership of 400,000 shares of Kyntra Bio, Inc. common stock, which represents 9.88% of the class. Both parties share voting and dispositive power over these shares, held directly by Armistice Capital Master Fund Ltd. …
T. Rowe Price Associates has reported an updated 6.3% beneficial ownership stake in Natera, Inc. (NTRA) through an amended Schedule 13G filing. The investment firm now holds 9,021,825 shares, with sole voting power over 8,605,302 shares and sole dispositive power over all 9,021,825 shares. …
An amended Schedule 13G/A filing reveals that American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute for Medical Research collectively hold an 11.8% beneficial stake in Entravision Communications Corporation (EVC), totaling 9,791,525 shares. American Century Capital Portfolios, Inc. separately holds …
This article provides the Q2 net income from continuing operations for Kyntra Bio Inc. The content seems to be a financial document detailing this specific metric.
BofA Securities has increased its price target for Concentra Group to $40 from the previous $36. The firm maintains a Neutral rating on the company's stock. This adjustment reflects a revised outlook on Concentra Group by BofA Securities.
RingCentral (RNG) stock has rallied significantly this year, returning 130.0% year-to-date, but it appears overvalued based on current checks. The company's P/E ratio of 48.1x is well above the industry average and the suggested fair P/E, indicating that investors are paying a premium for …
This article reports on a Form 144 SEC filing by CENTRAL GARDEN & PET CO (CENT) on August 13, 2026. The filing indicates a proposed sale of 3900 shares of Class A Common Stock, acquired through a gift in 2008, with an aggregate market …
Search by ticker symbol or company name and select a result to open its chart.